Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
AF

Andrew Christopher Flick — 9 Patents

Pfizer: 9 patents #561 of 5,153Top 15%
Carlsbad, CA: #586 of 2,500 inventorsTop 25%
California: #67,547 of 386,348 inventorsTop 20%
Overall (All Time): #535,341 of 4,157,543Top 15%
9 Patents All Time
Andrew Christopher Flick has been granted 9 US patents while listed as an inventor at Pfizer. The first was granted in 2017 and the most recent in May 2025. Andrew Christopher Flick ranks #535,341 of 4,157,543 US inventors in our database (top 12.9%). Patent records list Andrew Christopher Flick in Carlsbad, CA, US.

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12312344 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Brian Stephen Gerstenberger, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant +7 more 2025-05-27
11708360 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Brian Stephen Gerstenberger, Daniel Wei-Shung Kung, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant +7 more 2023-07-25 $554,221,000
10975065 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Brian Stephen Gerstenberger, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant, Ralph P. Robinson +7 more 2021-04-13 $1,297,023,000
10426135 Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Mark Edward Schnute, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more 2019-10-01 $298,967,000
10385036 Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof Mark Edward Schnute, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more 2019-08-20 $837,148,000
10336748 Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Mark Edward Schnute, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more 2019-07-02 $980,917,000
10308615 Heterocyclic compounds as inhibitors of Vanin-1 enzyme Agustin Casimiro-Garcia, Jeffrey Scott Condon, Ariamala Gopalsamy, Steven J. Kirincich, John Paul Mathias +4 more 2019-06-04 $869,926,000
10227346 Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof Mark Edward Schnute, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +6 more 2019-03-12 $419,848,000
9670201 Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Mark Edward Schnute, Peter Jones, Neelu Kaila, Scot Richard Mente, John David Trzupek +5 more 2017-06-06 $303,831,000